Your shopping cart is currently empty

Bufuralol (Ro 3-4787) is an orally active β-adrenergic receptor blocker with a certain degree of sympathomimetic effects and can be used to study cardiovascular diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $399 | 1-2 weeks | 1-2 weeks |
| Description | Bufuralol (Ro 3-4787) is an orally active β-adrenergic receptor blocker with a certain degree of sympathomimetic effects and can be used to study cardiovascular diseases. |
| In vitro | Bufuralol is a widely used substrate for assessing cytochrome P450 2D6 (CYP2D6) enzyme activity. By measuring the rate of metabolism of Bufuralol, the level of CYP2D6 activity in an individual or cell can be effectively assessed. [1] |
| In vivo | The metabolism of Bufuralol is mediated by NADPH-dependent cytochrome P450 enzymes (specifically CYP2D6) and exhibits biphasic kinetics. The metabolic efficiency of Bufuralol was significantly increased in the intestines of monkeys in the presence of hydroperoxyisopropylbenzene (CuOOH). The metabolism of Bufuralol exhibited biphasic kinetics mediated by NADPH and was more efficient in the presence of CuOOH, which was consistent with observations in the liver. [2] |
| Synonyms | Ro3-4787, Ro-3-4787, Ro 3-4787, RO 034787 |
| Molecular Weight | 261.36 |
| Formula | C16H23NO2 |
| Cas No. | 54340-62-4 |
| Smiles | OC(C=1OC2=C(C=CC=C2CC)C1)CNC(C)(C)C |
| Relative Density. | 1.066 g/cm3 (Predicted) |
| Storage | store at low temperature,keep away from direct sunlight | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (306.09 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.63 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.